清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Letter: bismuth, levofloxacin, amoxicillin, PPI quadruple therapy is not an effective first or second line regimen in the presence of levofloxacin resistance

作者
David Y. Graham,Hong Lü
出处
期刊:Alimentary Pharmacology & Therapeutics [Wiley]
卷期号:41 (11): 1220-1221 被引量:10
标识
DOI:10.1111/apt.13177
摘要

We believe the authors were misled in their analysis of the results of their recent trial of a levofloxacin, bismuth, amoxicillin and PPI quadruple therapy.1 They report a per protocol eradication rate of 91%. Despite this good overall outcome, the regimen would be expected to fail to overcome levofloxacin resistance. Overcoming levofloxacin resistance is defined as similar results with both levofloxacin-resistant and -susceptible strains. Here, those subjects with levofloxacin resistance must have experienced an unacceptably low cure rate.2, 3 Failure to examine the treatment outcome in relation to anti-microbial susceptibility makes this mistake inevitable.4, 5 For example, one expects treatment success with susceptible strains with a 14-day triple therapy consisting of PPI, amoxicillin, fluoroquinolone to be greater than 95% (i.e. about 97%).2, 6, 7 The outcome among those with fluoroquinolone-resistant infections depends entirely on treatment success with the PPI, bismuth, amoxicillin triple combination2, 3 (i.e. the population outcome depends greatly on the proportion with fluoroquinolone resistance). If success with resistant strains was 70%,2 the levofloxacin resistance rate in the Gisbert et al., study would be about 20% [i.e. (97% times (1−X) + (70% times X) = 91%].2, 4, 5 If it were closer to their predicted resistance rate of 15% in Spain, treatment success would have been approximately 60% (i.e. approximately 40% of those with resistance would fail therapy). No matter, the conclusion that the regimen was effective is incorrect. The regimen was highly effective for those with susceptible strains, but would be unacceptable for those with levofloxacin resistance. The proportion with susceptibility/resistance to levofloxacin defined the population results consisting of subpopulations receiving effective (e.g. 95–97% success) and ineffective therapy (e.g. 60–70% success) (Figure 1). This is another example of how failure to collect antibiotic susceptibility in a clinical trial leads to misleading conclusions regarding the effectiveness of a treatment trial. Thus, while their data are correct, their conclusions are wrong. Author contributions: Each of the authors have been involved equally and have read and approved the final manuscript. Each meets the criteria for authorship established by the International Committee of Medical Journal Editors and verify the validity of the results reported. Declaration of personal interests: David Y. Graham has served as a speaker, a consultant and an advisory board member for Otsuka Japan, RedHill Biopharm and BioGala, and has received research funding from RedHill Biopharm. Dr Graham has received royalties from Baylor College of Medicine patents covering materials related to 13C-urea breath test. Dr Lu has nothing to declare. Declaration of funding interests: Dr Graham was supported in part by the Office of Research and Development Medical Research Service Department of Veterans Affairs, Public Health Service grants DK067366 and DK56338, which funds the Texas Medical Center Digestive Diseases Center. The contents are solely the responsibility of the authors and do not necessarily represent the official views of the VA or NIH. Dr Lu is supported in part by grants from the National Natural Science Foundation of China (81170355 and 81370592).

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
睡不醒完成签到 ,获得积分10
12秒前
uuuu完成签到 ,获得积分10
13秒前
我很厉害的1q完成签到,获得积分10
29秒前
游泳池完成签到,获得积分10
33秒前
qianzhihe2完成签到,获得积分10
36秒前
隐形曼青应助研友_Z1eDgZ采纳,获得10
39秒前
桃花源的瓶起子完成签到 ,获得积分10
43秒前
Axs完成签到,获得积分10
47秒前
It完成签到 ,获得积分10
48秒前
50秒前
复杂易巧发布了新的文献求助10
54秒前
复杂易巧完成签到,获得积分20
1分钟前
善良的冰绿完成签到,获得积分10
1分钟前
ninini完成签到 ,获得积分10
1分钟前
1分钟前
king完成签到 ,获得积分10
1分钟前
hmhu发布了新的文献求助10
1分钟前
科研通AI6.4应助小静采纳,获得10
1分钟前
cat应助科研通管家采纳,获得10
1分钟前
兜有米完成签到 ,获得积分10
1分钟前
陈俊雷完成签到 ,获得积分0
2分钟前
zdp827完成签到 ,获得积分10
2分钟前
Bella完成签到 ,获得积分10
2分钟前
zjh123完成签到,获得积分10
2分钟前
2分钟前
科研通AI6.4应助小静采纳,获得10
2分钟前
研友_Z1eDgZ发布了新的文献求助10
2分钟前
秋雨梧桐完成签到 ,获得积分10
2分钟前
fd完成签到 ,获得积分10
3分钟前
Cherry完成签到 ,获得积分10
3分钟前
细腻梦凡完成签到,获得积分10
3分钟前
蝎子莱莱xth完成签到,获得积分0
3分钟前
氢锂钠钾铷铯钫完成签到,获得积分10
3分钟前
3分钟前
烟花应助科研通管家采纳,获得10
3分钟前
Square完成签到,获得积分10
3分钟前
wood完成签到,获得积分10
3分钟前
喜悦的绮露完成签到 ,获得积分10
3分钟前
小静发布了新的文献求助10
3分钟前
笔墨纸砚完成签到 ,获得积分10
3分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
China Pluperfect I: Epistemology of Past and Outside in Chinese Art 520
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
基于锂离子电池正极材料回收的绿色溶剂开发及工程化应用研究 500
Auslegungsgeschichte 500
Transdermal drug delivery systems market size report 500
Cosmos as Art Object: Studies in Plato's Timaeus and Other Dialogues 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7640456
求助须知:如何正确求助?哪些是违规求助? 9213463
关于积分的说明 19763511
捐赠科研通 7206352
什么是DOI,文献DOI怎么找? 3276078
关于科研通互助平台的介绍 2437709
邀请新用户注册赠送积分活动 2273531